Editorial Board

Editor-in-Chief

Dr. Swathi Merugu
Immune Monitoring Core Facility at Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, USA

E-mail address: merugus@mskcc.org

Dr. Swathi Merugu is an immunologist who studies the role of the immune system in various cancers and work on clinical trials majorly focused on Immunotherapy in various cancers. The overarching goal of her research is to develop new immunological assays to investigate the role of different immune populations in cancers before and after treatment with Immunotherapeutic agents. Her work has practical applications in finding patients for enrolling into precision medicine trials based on biomarkers in patient blood samples and suggesting oncologists for possible treatment options with investigational new drugs. Her Ph.D research is the first study in the world to demonstrate the clinical utility of neuroblastoma circulating tumor cells (CTCs) detected by the ISx (Imagestream cytometer) as noninvasive pharmacodynamic biomarkers of novel therapies in early-phase clinical trials. Currently, her work is majorly focused on working on many phase I and phase II clinical trials where she’s developing novel immune-based assays to find out the significant contribution of immune subsets before the treatment with immunotherapy comparing the immune subset populations during and after the treatment helping the oncologist for choosing the best treatment options in Immune related cancers.


Editorial Board

Dr. Akondi Butchi Raju
Department of Clinical Pharmacy and Pharmacology, Ibn Sina National College for Medical Studies, Jeddah
Saudi Arabia

E-mail address: drraju2020@gmail.com

Dr. Siva Reddy Challa
Department of Cancer Biology & Pharmacology, University of Illinois College of Medicine, Peoria, Illinois, USA

E-mail address: sivareddypharma@gmail.com

Prof. Annapurna Akula
Department of Pharmacology, College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, India

Prof. Elaine Elisabetsky
Departamento de Farmacologia, Universidade Federal do Rio Grande do Sul, Brazil

Prof. Venkata Krishna Raju Alluri
Laila Nutraceuticals R&D Centre, JRD Tata Industrial Estate, Vijayawada, India

Prof. Astghik Z. Pepoyan
Food Safety & Biotechnology, Armenian National Agrarian University, Yerevan, Armenia

Prof. Hemant Kumar
Department of Pharmacology, NIPER-Ahmedabad, Gujarat, India

Dr. Srinivasa Reddy Bonam
Institut National de la Santé et de la Recherche Médicale; Centre de Recherche des Cordeliers, Equipe-Immunopathologie et Immunointervention Thérapeutique, Sorbonne Université, Université de Paris, France

Dr. Ch V. Rao
CSIR-National Botanical Research Institute, Ranapratap Marg, Lucknow, Uttar Pradesh, India

Prof. Sushruta Koppula
College of Biomedical and Health Sciences, Konkuk University, Chungbuk-Do, South Korea

Dr. Ashok Mandala
Harold Hamm Diabetes Center, The University of Oklahoma Health Sciences Center, Oklahoma City, USA

Dr. Mahendran Sekar
Faculty of Pharmacy and Health Sciences, Universiti Kuala Lumpur Royal College of Medicine Perak, Malaysia

Prof. Y. Narsimha Reddy
Faculty of Pharmaceutical Sciences, University College of Pharmaceutical Sciences, Kakatiya University, Warangal, India

Dr. Sridhar Vemulapalli
Cipla Pharmaceuticals, New York, NY, USA